Intracellular calcium and myosin isoform transitions - Calcineurin and calcium-calmodulin kinase pathways regulate preferential activation of the iia myosin heavy chain promoter
被引:85
作者:
Allen, DL
论文数: 0引用数: 0
h-index: 0
机构:
Univ Colorado, Dept Mol Cellular & Dev Biol, Boulder, CO 80309 USAUniv Colorado, Dept Mol Cellular & Dev Biol, Boulder, CO 80309 USA
Allen, DL
[1
]
Leinwand, LA
论文数: 0引用数: 0
h-index: 0
机构:
Univ Colorado, Dept Mol Cellular & Dev Biol, Boulder, CO 80309 USAUniv Colorado, Dept Mol Cellular & Dev Biol, Boulder, CO 80309 USA
Leinwand, LA
[1
]
机构:
[1] Univ Colorado, Dept Mol Cellular & Dev Biol, Boulder, CO 80309 USA
Intracellular calcium levels can have profound effects on muscle biology via alterations in gene expression. In particular, intracellular calcium levels increase during muscle activation and are thought to underlie fast-to-slow shifts in muscle gene expression. In the present work, we determined that increased intracellular calcium has a significant effect on the activity of the adult fast myosin heavy chain (MyHC) promoters in the order of MyHC IIa much greater than IId/x > IIb. We have identified the pathways by which the calcium signal mediates increased activation of the MyHC IIa promoter. Inhibition of calcineurin or calcium-calmodulin kinase greatly attenuates ionophore-induced activation of the MyHC IIa promoter, whereas protein kinase C inhibitors have no effect. Inhibition and overexpression studies with members of the mitogen-activated protein kinase family reveal roles for MEK1/MEK2 and MEKK1, but not p38 or phosphatidylinositol 3-kinase. Downstream mediators of these effects are the activities of the MEF-2 and NFAT transcription factors, whose binding sites in the MyHC IIa promoter are required for calcium-induced activation of the MyHC IIa promoter.
机构:
Washington Univ, Sch Med, Div Endocrinol Diabet & Metab, St Louis, MO 63110 USAWashington Univ, Sch Med, Div Endocrinol Diabet & Metab, St Louis, MO 63110 USA
Bernal-Mizrachi, E
Wice, B
论文数: 0引用数: 0
h-index: 0
机构:
Washington Univ, Sch Med, Div Endocrinol Diabet & Metab, St Louis, MO 63110 USAWashington Univ, Sch Med, Div Endocrinol Diabet & Metab, St Louis, MO 63110 USA
Wice, B
Inoue, H
论文数: 0引用数: 0
h-index: 0
机构:
Washington Univ, Sch Med, Div Endocrinol Diabet & Metab, St Louis, MO 63110 USAWashington Univ, Sch Med, Div Endocrinol Diabet & Metab, St Louis, MO 63110 USA
Inoue, H
Permutt, MA
论文数: 0引用数: 0
h-index: 0
机构:
Washington Univ, Sch Med, Div Endocrinol Diabet & Metab, St Louis, MO 63110 USAWashington Univ, Sch Med, Div Endocrinol Diabet & Metab, St Louis, MO 63110 USA
机构:
Washington Univ, Sch Med, Div Endocrinol Diabet & Metab, St Louis, MO 63110 USAWashington Univ, Sch Med, Div Endocrinol Diabet & Metab, St Louis, MO 63110 USA
Bernal-Mizrachi, E
Wice, B
论文数: 0引用数: 0
h-index: 0
机构:
Washington Univ, Sch Med, Div Endocrinol Diabet & Metab, St Louis, MO 63110 USAWashington Univ, Sch Med, Div Endocrinol Diabet & Metab, St Louis, MO 63110 USA
Wice, B
Inoue, H
论文数: 0引用数: 0
h-index: 0
机构:
Washington Univ, Sch Med, Div Endocrinol Diabet & Metab, St Louis, MO 63110 USAWashington Univ, Sch Med, Div Endocrinol Diabet & Metab, St Louis, MO 63110 USA
Inoue, H
Permutt, MA
论文数: 0引用数: 0
h-index: 0
机构:
Washington Univ, Sch Med, Div Endocrinol Diabet & Metab, St Louis, MO 63110 USAWashington Univ, Sch Med, Div Endocrinol Diabet & Metab, St Louis, MO 63110 USA